JinHui Liu (Jinhui Liu)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 20

Top Topics

Long Noncoding Rna

Endometrial Cancer

Newly Diagnosed

Peritoneal Dialysis

Top Venues

Oxidative medicine and cellular longevity

International journal of molecular sciences

Journal of oncology

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Zihan Zhu, Rui Geng, Yixin Zhang, JinHui Liu, Jianling Bai
Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients. Journal of immunology research 2023 (2023)
Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Yang Jiao, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, JinHui Liu, Jianling Bai
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. International journal of molecular sciences 24 (2) (2023)
Yang Jiao, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, JinHui Liu, Jianling Bai
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. International journal of molecular sciences 24 (2) (2023)
Yang Jiao, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, JinHui Liu, Jianling Bai
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. International journal of molecular sciences 24 (2) (2023)
Zihan Zhu, Rui Geng, Yixin Zhang, JinHui Liu, Jianling Bai
Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients. Journal of immunology research 2023 (2023)
Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Yang Jiao, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, JinHui Liu, Jianling Bai
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. International journal of molecular sciences 24 (2) (2023)
Yang Jiao, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, JinHui Liu, Jianling Bai
A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. International journal of molecular sciences 24 (2) (2023)
Xiaofang Tan, Shuang Liu, Liangyu Yao, Guoliang Cui, JinHui Liu, Jiayi Ding
Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma. Journal of oncology 2022 (2022)
Rui Geng, Tian Chen, Zihang Zhong, Senmiao Ni, Jianling Bai, JinHui Liu
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer. Cancers 14 (16) (2022)
JinHui Liu, Yuanyuan Wang, Jian Yin, Yan Yang, Rui Geng, Zihang Zhong, Senmiao Ni, Wen Liu, Mulong Du, Hao Yu, Jianling Bai
Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy. Journal of oncology 2022 (2022)
Zihang Zhong, Yuanyuan Wang, Jian Yin, Senmiao Ni, Wen Liu, Rui Geng, JinHui Liu, Jianling Bai, Hao Yu
Identification of Specific Cervical Cancer Subtypes and Prognostic Gene Sets in Tumor and Nontumor Tissues Based on GSVA Analysis. Journal of oncology 2022 (2022)
Rui Geng, Jiahang Song, Zihang Zhong, Senmiao Ni, Wen Liu, Zhiqiang He, Shilin Gan, Qinghao Huang, Hao Yu, Jianling Bai, JinHui Liu
Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma. Cancers 14 (14) (2022)
JinHui Liu, Rui Geng, Zihang Zhong, Yixin Zhang, Senmiao Ni, Wen Liu, Mulong Du, Jianling Bai
N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma. Oxidative medicine and cellular longevity 2022 (2022)
Nan Lu, JinHui Liu, Chengjian Ji, Yichun Wang, Zhipeng Wu, Shuning Yuan, Yan Xing, Feiyang Diao
MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer. Bioengineered 12 (1) (2021)
Cheng Zhang, JinHui Liu, Hongyu Guo, Dandan Hong, Jing Ji, Qin Zhang, Qun Guan, Qingling Ren
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered 12 (1) (2021)